Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis
Journal of Thrombosis and Haemostasis · 2025-10 · 23 (10) · 3327-3335
DOI: 10.1016/j.jtha.2025.07.012 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-10. Verfasst von Saarang R Deshpande und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Purpura, Thrombotic Thrombocytopenic, Splenectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Pfizer.
Abstract (Originalsprache)
BACKGROUND: Immune thrombotic thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy caused by autoantibody-mediated ADAMTS-13 deficiency. Historically, splenectomy was used for multiply relapsing iTTP in clinical remission to lessen risk of relapse and as treatment for plasma-refractory or plasma-dependent iTTP. OBJECTIVES: To evaluate the effectiveness of splenectomy on relapse in relapsing iTTP and on remission in plasma-refractory and palsma-dependent iTTP. METHODS: We conducted a systematic review and meta-analysis of 2 questions related to splenectomy for iTTP: (1) in patients with relapsing iTTP, what is the effect of splenectomy on the iTTP relapse rate? (2) In patients with plasma-refractory or plasma-dependent iTTP, what proportion of patients achieve clinical remission after splenectomy? Three electronic databases (Embase, PubMed, and Scopus) were searched for keywords related to thrombotic thrombocytopenic purpura and splenectomy, and screening was completed following PRISMA guidelines. RESULTS: Twenty-three studies were included, representing 62 patients (with 205.8 years of follow-up) who underwent splenectomy for relapsing iTTP and 57 patients (with 173.9 years of follow-up; not reported in 3 studies) who underwent splenectomy for plasma-refractory/dependent iTTP. In patients who underwent splenectomy for relapsing iTTP, there were 1.80 (95% CI, -2.66 to -0.95) fewer iTTP episodes annually after splenectomy compared with before splenectomy. For patients who underwent splenectomy for plasma-refractory/dependent iTTP, the proportion of patients achieving clinical remission was 0.87 (95% CI, 0.76-0.93). Only 2 studies included any patients who received rituximab. CONCLUSION: There is low-quality evidence to support the use of splenectomy for multiply relapsing iTTP to decrease relapse rate and for plasma-refractory/dependent iTTP to achieve remission, noting that most of the evidence precedes the routine use of rituximab in iTTP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: Saarang.r.deshpande@gmail.com.
- Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Biostatistics, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; The Center for Health Artifical Intelligence and Synthesis of Evidence…
- Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Pathology and Laboratory Medicine, Perelman School of…
Förderung
- Pfizer
Zitieren
APA
Deshpande, S. R., Tarawneh, H., Tong, J., Zhou, T., Chen, Y., & Cuker, A. (2025). Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 23(10), 3327-3335. https://doi.org/10.1016/j.jtha.2025.07.012
Vancouver
Deshpande SR, Tarawneh H, Tong J, Zhou T, Chen Y, Cuker A. Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 2025;23(10):3327-3335. doi:10.1016/j.jtha.2025.07.012
BibTeX
@article{Deshpande2025,
author = {Deshpande, Saarang R and Tarawneh, Hemza and Tong, Jiayi and Zhou, Ting and Chen, Yong and Cuker, Adam},
title = {Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
volume = {23},
number = {10},
pages = {3327--3335},
doi = {10.1016/j.jtha.2025.07.012}
}
EUVIMED